Heartflow director granted 16,075 stock options

Heartflow, Inc. reported that director Julie A. Cullivan received a grant of stock options covering 16,075 shares of common stock.

Rhea-AI Filing Summary

Heartflow, Inc. reported that director Julie A. Cullivan received a grant of stock options covering 16,075 shares of common stock. The options have an exercise price of $32.05 per share and expire on June 16, 2036.

According to the terms, the option will vest in full on the earlier of the day prior to Heartflow's annual meeting of shareholders in 2027 or the first anniversary of the grant date, subject to her continued service through that date. This filing reflects a compensation-related award, with no share sales reported.

Insider Trade Summary

Grant/Award: 16,075 shares

Grant/Award 1 txn

Insider Cullivan Julie A

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option	16,075	$32.05	$515K

Holdings After Transaction: Stock Option — 16,075 contracts (Direct)

Footnotes (1)

1. F1. The option will vest in full on the earlier of the day prior to Heartflow's annual meeting of shareholders in 2027 and the first anniversary of the grant date, subject to continued service through such date.

Key Figures

Option grant size: 16,075 shares Exercise price: $32.05 per share Expiration date: June 16, 2036 +1 more

4 metrics

Option grant size 16,075 shares Stock option covering underlying common stock

Exercise price $32.05 per share Strike price of stock option grant

Expiration date June 16, 2036 Option term end date

Shares following transaction 16,075 derivative units Total stock options held after grant

Key Terms

Stock Option, grant/award acquisition, expiration date, annual meeting of shareholders

4 terms

Stock Option financial

"security_title: "Stock Option""

A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

grant/award acquisition financial

"transaction_action: "grant/award acquisition""

expiration date financial

"expiration_date: "2036-06-16T00:00:00.000Z""

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

annual meeting of shareholders financial

"the day prior to Heartflow's annual meeting of shareholders in 2027"

A yearly gathering where a company’s owners (shareholders) vote on key items like electing the board, approving executive pay, and ratifying auditors, and receive updates on performance and strategy. Think of it as an annual town hall for owners: it matters to investors because outcomes and disclosures can affect leadership, corporate direction, dividend and governance policies, and therefore the company’s risk and potential return.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Heartflow (HTFL) report for Julie A. Cullivan?

Heartflow reported that director Julie A. Cullivan received a grant of stock options for 16,075 underlying common shares. The options were awarded as compensation, with no open-market share purchases or sales disclosed in this Form 4 filing.

What is the exercise price of Julie Cullivan’s Heartflow (HTFL) stock options?

The exercise price of Julie Cullivan’s Heartflow stock options is $32.05 per share. This means she can buy up to 16,075 common shares at $32.05 each once the options vest, regardless of Heartflow’s future market price.

When do Julie Cullivan’s Heartflow (HTFL) stock options vest?

The stock options vest in full on the earlier of the day before Heartflow’s 2027 annual shareholder meeting or the first anniversary of the grant date. Vesting is contingent on Julie Cullivan’s continued service through that vesting date.

When do Julie Cullivan’s Heartflow (HTFL) stock options expire?

Julie Cullivan’s Heartflow stock options expire on June 16, 2036. After that expiration date, any unexercised portion of the 16,075-share option grant can no longer be used to purchase Heartflow common stock at the stated exercise price.

Did Julie Cullivan buy or sell Heartflow (HTFL) shares in this Form 4?

No, this Form 4 reports a grant of stock options, not a market trade. Julie Cullivan acquired derivative rights to 16,075 shares as compensation, with no reported open-market buying or selling of Heartflow common stock in this filing.

What type of security did Julie Cullivan receive from Heartflow (HTFL)?

She received a stock option, which is a derivative security giving the right to buy common shares at a fixed price. The grant covers 16,075 underlying Heartflow common shares at an exercise price of $32.05 per share, expiring in 2036.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/18/2026 - 05:30 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cullivan Julie A

(Last) (First) (Middle)

C/O HEARTFLOW, INC.

135 MAIN STREET, SUITE 1000

(Street)

SAN FRANCISCO CALIFORNIA 94105

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Heartflow, Inc. [ HTFL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	$32.05	06/16/2026		A		16,075		(1)	06/16/2036	Common Stock	16,075	$32.05	16,075	D

Explanation of Responses:

1. The option will vest in full on the earlier of the day prior to Heartflow's annual meeting of shareholders in 2027 and the first anniversary of the grant date, subject to continued service through such date.

	/s/ Nga Van, by power of attorney	06/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)